INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Clinical trial / 2019

Vitamin D supplementation in deficient elderly individuals modulated immune markers after influenza vaccination without improving antibody titers.

Elderly individuals with vitamin D deficiency were randomized to receive either 100,000 IU/15 days of cholecalciferol (n = 19) or placebo (n = 19) for 3 months, followed by influenza vaccination and immune evaluation 28 days later. Serum 25-(OH)D increased in the supplementation group (20.7 ± 5.7 to 44.3 ± 8.6 ng/mL, p < 0.001). Supplementation led to lower plasma levels of TNFα (p = 0.040) and IL-6 (p = 0.046), higher TGFβ (p = 0.0028), and a lower Th1/Th2 ratio prior to vaccination (0.12 ± 0.05 vs. 0.18 ± 0.05, p = 0.039). However, no differences were found between groups for antibody titers, serum cathelicidin levels, or ROS production.

Study type
Randomized placebo-controlled double-blind trial
Who was studied
38 vitamin D-deficient elderly persons (serum <30 ng/mL)
What was measured
Influenza seroprotection, antibody titers, serum cathelicidin, plasma cytokines, lymphocyte phenotyping, phagocyte ROS production

THE PAPER

Impact of Vitamin D Supplementation on Influenza Vaccine Response and Immune Functions in Deficient Elderly Persons: A Randomized Placebo-Controlled Trial.

Goncalves-Mendes N, Talvas J, Dualé C, Guttmann A, Corbin V, Marceau G, Sapin V, Brachet P, Evrard B, Laurichesse H, Vasson MP. Front Immunol, 2019.

PubMed 30800121 ↗DOI 10.4049/jimmunol.0802217 ↗

Nutrients & adequacyHealthy aging & longevityOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.